Ionis Pharmaceuticals, Inc.
IONS
$26.58-0.64 (2.35%)Nov 20
After-hours: $26.80 (+0.83%)
Ionis Pharmaceuticals, Inc. (IONS)
$26.58-0.64-2.35%Nov 20
Loading chart…
USA›Health Care›Biotechnology›Biotechnology
YTD-66%
M.cap.4.4 bn
Std.Dev, 1y-2.55
Vol, bn0.1 (high)
RSI14 (oversold)
P/E—
MFI21 (oversold)
P/S4.79
ADX50 (trend)
P/B11.25
Beta0.60
Div—
Debt/EBITDA—
Payout—
Price target
Buy 19 (86%)Hold 3 (14%)Sell 0 (0%)
Next earnings—
Earnings surprise
Short interest12.8% (+0.3%), 30 Oct 2026
Fund owners #365 (-179)
Insider ownership$171 mm
Insider sellingVery Low
Insider buyingHigh
General
M.Cap$4.4B
Dividends—
Next report—
Forecast
Valuation
Target
P/E—
P/S4.79
P/B11.25
Fundamentals
5-y avg sales growth+5.3%
Debt / EBITDA0.00
ROE—
Altman Z-score2.12 (grey zone)
Technicals
RSI14
MFI21
Price / MA50-34.8% (v.low) ↓
Trend pattern
Financial Statements
No data available
Financial Statements
No data available
Team
Loading…
Team
Loading…
Leadership Changes
Sign in to view leadership changes
Sign in
No changes found
Insider Activity
Loading…
Insider Activity
Loading…
DateTypeDescription
Loading…
Earnings Transcripts
Loading…
Earnings Transcripts
Loading…
Dividends
Loading…
Dividends
Loading…
Investor Presentations
Loading…
Investor Presentations
Loading…
Options
Exp. from:to:
Strike from:to:
Loading…
Options
Expiration from:
to:
Strike from:
to:
Loading options…
Loading bonds…
Stress Test
Loading…
Stress Test
Loading…
About

Ionis Pharmaceuticals is a biopharmaceutical company that discovers and develops RNA-targeted therapeutics in the US. Its products include treatments for spinal muscular atrophy (SMA), polyneuropathy, familial lipodystrophy and familial chylomicronemia syndrome. Additionally, the company develops medicines for diseases such as metabolic diseases, infectious diseases, ophthalmic diseases, cancer, and renal diseases.

WikipediaHeadcount: 1,485
Website: www.ionis.com
Address:2855 Gazelle Court, Carlsbad, CA, United States, 92010
About

Ionis Pharmaceuticals is a biopharmaceutical company that discovers and develops RNA-targeted therapeutics in the US. Its products include treatments for spinal muscular atrophy (SMA), polyneuropathy, familial lipodystrophy and familial chylomicronemia syndrome. Additionally, the company develops medicines for diseases such as metabolic diseases, infectious diseases, ophthalmic diseases, cancer, and renal diseases.

https://www.ionis.com
Beta 0.60